ERWINAZE is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Asparaginase Erwinia Chrysanthemi.
Product ID | 57902-249_4da45931-b925-4f47-9cf1-4fcfb12c5b29 |
NDC | 57902-249 |
Product Type | Human Prescription Drug |
Proprietary Name | ERWINAZE |
Generic Name | Asparaginase |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2011-11-18 |
Marketing Category | BLA / BLA |
Application Number | BLA125359 |
Labeler Name | Jazz Pharmaceuticals, Inc. |
Substance Name | ASPARAGINASE ERWINIA CHRYSANTHEMI |
Active Ingredient Strength | 10000 [iU]/mL |
Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2011-11-18 |
Marketing End Date | 2021-07-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-11-18 |
Marketing Category | BLA |
Application Number | BLA125359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-11-18 |
Ingredient | Strength |
---|---|
ASPARAGINASE ERWINIA CHRYSANTHEMI | 10000 [iU]/mL |
SPL SET ID: | 30bdf2ea-008b-4cbb-81e4-c3474f2ad286 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
57902-249 | ERWINAZE | Asparaginase |
81561-413 | ERWINASE | asparaginase |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ERWINAZE 90081574 not registered Live/Pending |
Porton Biopharma Limited 2020-07-29 |
ERWINAZE 85245951 4147569 Live/Registered |
PORTON BIOPHARMA LIMITED 2011-02-18 |
ERWINAZE 85031446 not registered Dead/Abandoned |
EUSA Pharma (Europe) Limited 2010-05-06 |